Gal4p gene transcriptions: Difference between revisions
mNo edit summary |
|||
(4 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
==Human genes== | ==Human genes== | ||
{{main|Human genes}} | |||
==Interactions== | ==Interactions== | ||
{{main|Interaction gene transcriptions}} | |||
"During the induction of galactose, the production of Gal4p can improve the PGAL1 activity 1000-fold [37]."<ref name=Tang/> | |||
" | "We used the yeast Gal4p two-hybrid system (Fields and Sternglanz, 1994) to identify proteins that physically interact with GLD-1. We recovered two identical cDNAs in two-hybrid screens [...]. One (OG2.3) using GLD-1 residues 84-341 and the other (CD13.1) using residues 273-457, both fused to the Gal4p DNA binding domain [...]."<ref name=Clifford>{{ cite journal | ||
|author=Robert Clifford, Min-Ho Lee, Sudhir Nayak, Mitsue Ohmachi, Flav Giorgini and Tim Schedl | |||
|title=FOG-2, a novel F-box containing protein, associates with the GLD-1 RNA binding protein and directs male sex determination in the ''C. elegans'' hermaphrodite germline | |||
|journal=Development | |||
|date=December 2000 | |||
|volume=127 | |||
|issue=24 | |||
|pages=5265-76 | |||
|url=https://dev.biologists.org/content/develop/127/24/5265.full.pdf | |||
|arxiv= | |||
|bibcode= | |||
|doi= | |||
|pmid=11076749 | |||
|accessdate=10 August 2020 }}</ref> | |||
==Consensus sequences== | ==Consensus sequences== | ||
{{main|Consensus sequence gene transcriptions}} | |||
Upstream activating sequence for Gal4p is 5'-CGG(A/G)NN(A/G)C(C/T)N(C/T)NCNCCG-3' [38].<ref name=Tang>{{ cite journal | Upstream activating sequence for Gal4p is 5'-CGG(A/G)NN(A/G)C(C/T)N(C/T)NCNCCG-3' [38].<ref name=Tang>{{ cite journal | ||
|author=Hongting Tang, Yanling Wu, Jiliang Deng, Nanzhu Chen, Zhaohui Zheng, Yongjun Wei, Xiaozhou Luo, and Jay D. Keasling | |author=Hongting Tang, Yanling Wu, Jiliang Deng, Nanzhu Chen, Zhaohui Zheng, Yongjun Wei, Xiaozhou Luo, and Jay D. Keasling | ||
Line 27: | Line 43: | ||
|pmid=32781665 | |pmid=32781665 | ||
|accessdate=18 September 2020 }}</ref> | |accessdate=18 September 2020 }}</ref> | ||
==Hypotheses== | |||
{{main|Hypotheses}} | |||
# A1BG has no Gal4ps in either promoter. | |||
# A1BG is not transcribed by a Gal4p. | |||
# Gal4p does not participate in the transcription of A1BG. | |||
==Samplings== | ==Samplings== | ||
Copying 5'-CGGACCGC-3' in "⌘F" yields none between ZSCAN22 and A1BG and none between ZNF497 and A1BG as can be found by the computer programs. | Copying 5'-CGGACCGC-3' in "⌘F" yields none between ZSCAN22 and A1BG and none between ZNF497 and A1BG as can be found by the computer programs. | ||
For the Basic programs testing consensus sequence CGG(A/G)NN(A/G)C(C/T)N(C/T)NCNCCG (starting with SuccessablesGal4.bas) written to compare nucleotide sequences with the sequences on either the template strand (-), or coding strand (+), of the DNA, in the negative direction (-), or the positive direction (+), the programs are, are looking for, and found: | |||
# negative strand, negative direction, looking for CGG(A/G)NN(A/G)C(C/T)N(C/T)NCNCCG, 0. | |||
# negative strand, positive direction, looking for CGG(A/G)NN(A/G)C(C/T)N(C/T)NCNCCG, 0. | |||
# positive strand, negative direction, looking for CGG(A/G)NN(A/G)C(C/T)N(C/T)NCNCCG, 0. | |||
# positive strand, positive direction, looking for CGG(A/G)NN(A/G)C(C/T)N(C/T)NCNCCG, 0. | |||
# complement, negative strand, negative direction, looking for GCC(C/T)NN(C/T)G(A/G)N(A/G)NGNGGC, 0. | |||
# complement, negative strand, positive direction, looking for GCC(C/T)NN(C/T)G(A/G)N(A/G)NGNGGC, 0. | |||
# complement, positive strand, negative direction, looking for GCC(C/T)NN(C/T)G(A/G)N(A/G)NGNGGC, 0. | |||
# complement, positive strand, positive direction, looking for GCC(C/T)NN(C/T)G(A/G)N(A/G)NGNGGC, 0. | |||
# inverse complement, negative strand, negative direction, looking for CGGNGN(A/G)N(A/G)G(C/T)NN(C/T)CCG, 0. | |||
# inverse complement, negative strand, positive direction, looking for CGGNGN(A/G)N(A/G)G(C/T)NN(C/T)CCG, 0. | |||
# inverse complement, positive strand, negative direction, looking for CGGNGN(A/G)N(A/G)G(C/T)NN(C/T)CCG, 0. | |||
# inverse complement, positive strand, positive direction, looking for CGGNGN(A/G)N(A/G)G(C/T)NN(C/T)CCG, 0. | |||
# inverse negative strand, negative direction, looking for GCCNCN(C/T)N(C/T)C(A/G)NN(A/G)GGC, 0. | |||
# inverse negative strand, positive direction, looking for GCCNCN(C/T)N(C/T)C(A/G)NN(A/G)GGC, 0. | |||
# inverse positive strand, negative direction, looking for GCCNCN(C/T)N(C/T)C(A/G)NN(A/G)GGC, 0. | |||
# inverse positive strand, positive direction, looking for GCCNCN(C/T)N(C/T)C(A/G)NN(A/G)GGC, 0. | |||
==Acknowledgements== | |||
The content on this page was first contributed by: Henry A. Hoff. | |||
==See also== | ==See also== | ||
{{div col|colwidth=20em}} | {{div col|colwidth=20em}} | ||
* [[A1BG gene transcription core promoters]] | |||
* [[A1BG gene transcriptions]] | |||
* [[A1BG regulatory elements and regions]] | |||
* [[A1BG response element negative results]] | |||
* [[A1BG response element positive results]] | |||
* [[Complex locus A1BG and ZNF497]] | * [[Complex locus A1BG and ZNF497]] | ||
{{Div col end}} | {{Div col end}} | ||
Line 42: | Line 90: | ||
==External links== | ==External links== | ||
* [http://www.genome.jp/ GenomeNet KEGG database] | |||
* [http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene Home - Gene - NCBI] | |||
* [http://www.ncbi.nlm.nih.gov/sites/gquery NCBI All Databases Search] | |||
* [http://www.ncbi.nlm.nih.gov/ncbisearch/ NCBI Site Search] | |||
* [http://www.ncbi.nlm.nih.gov/pccompound PubChem Public Chemical Database] | |||
<!-- footer templates --> | <!-- footer templates --> | ||
Line 47: | Line 100: | ||
<!-- footer categories --> | <!-- footer categories --> | ||
[[Category:Resources last modified in | [[Category:Resources last modified in December 2020]] |
Latest revision as of 22:28, 31 December 2020
Associate Editor(s)-in-Chief: Henry A. Hoff
"PGAL1 is often used repeatedly for the expression of different enzymes in the construction of metabolic pathways [13], so the gene copy number has to be increased to compensate for the insufficient promoter strength [8], and the utilization of too many galactose-inducible promoters may interfere with the metabolism of galactose due to the depletion of the transcription activator Gal4p [14]."[1]
Galactose-inducible "promoters have various conserved UASGAL sites, a 17-bp consensus sequence 5′-CCGNNNNNNNNNNNCGG-3′ that is recognized by the transcription activator Gal4p to control their expression activities [38]."[1]
Human genes
Interactions
"During the induction of galactose, the production of Gal4p can improve the PGAL1 activity 1000-fold [37]."[1]
"We used the yeast Gal4p two-hybrid system (Fields and Sternglanz, 1994) to identify proteins that physically interact with GLD-1. We recovered two identical cDNAs in two-hybrid screens [...]. One (OG2.3) using GLD-1 residues 84-341 and the other (CD13.1) using residues 273-457, both fused to the Gal4p DNA binding domain [...]."[2]
Consensus sequences
Upstream activating sequence for Gal4p is 5'-CGG(A/G)NN(A/G)C(C/T)N(C/T)NCNCCG-3' [38].[1]
Hypotheses
- A1BG has no Gal4ps in either promoter.
- A1BG is not transcribed by a Gal4p.
- Gal4p does not participate in the transcription of A1BG.
Samplings
Copying 5'-CGGACCGC-3' in "⌘F" yields none between ZSCAN22 and A1BG and none between ZNF497 and A1BG as can be found by the computer programs.
For the Basic programs testing consensus sequence CGG(A/G)NN(A/G)C(C/T)N(C/T)NCNCCG (starting with SuccessablesGal4.bas) written to compare nucleotide sequences with the sequences on either the template strand (-), or coding strand (+), of the DNA, in the negative direction (-), or the positive direction (+), the programs are, are looking for, and found:
- negative strand, negative direction, looking for CGG(A/G)NN(A/G)C(C/T)N(C/T)NCNCCG, 0.
- negative strand, positive direction, looking for CGG(A/G)NN(A/G)C(C/T)N(C/T)NCNCCG, 0.
- positive strand, negative direction, looking for CGG(A/G)NN(A/G)C(C/T)N(C/T)NCNCCG, 0.
- positive strand, positive direction, looking for CGG(A/G)NN(A/G)C(C/T)N(C/T)NCNCCG, 0.
- complement, negative strand, negative direction, looking for GCC(C/T)NN(C/T)G(A/G)N(A/G)NGNGGC, 0.
- complement, negative strand, positive direction, looking for GCC(C/T)NN(C/T)G(A/G)N(A/G)NGNGGC, 0.
- complement, positive strand, negative direction, looking for GCC(C/T)NN(C/T)G(A/G)N(A/G)NGNGGC, 0.
- complement, positive strand, positive direction, looking for GCC(C/T)NN(C/T)G(A/G)N(A/G)NGNGGC, 0.
- inverse complement, negative strand, negative direction, looking for CGGNGN(A/G)N(A/G)G(C/T)NN(C/T)CCG, 0.
- inverse complement, negative strand, positive direction, looking for CGGNGN(A/G)N(A/G)G(C/T)NN(C/T)CCG, 0.
- inverse complement, positive strand, negative direction, looking for CGGNGN(A/G)N(A/G)G(C/T)NN(C/T)CCG, 0.
- inverse complement, positive strand, positive direction, looking for CGGNGN(A/G)N(A/G)G(C/T)NN(C/T)CCG, 0.
- inverse negative strand, negative direction, looking for GCCNCN(C/T)N(C/T)C(A/G)NN(A/G)GGC, 0.
- inverse negative strand, positive direction, looking for GCCNCN(C/T)N(C/T)C(A/G)NN(A/G)GGC, 0.
- inverse positive strand, negative direction, looking for GCCNCN(C/T)N(C/T)C(A/G)NN(A/G)GGC, 0.
- inverse positive strand, positive direction, looking for GCCNCN(C/T)N(C/T)C(A/G)NN(A/G)GGC, 0.
Acknowledgements
The content on this page was first contributed by: Henry A. Hoff.
See also
References
- ↑ 1.0 1.1 1.2 1.3 Hongting Tang, Yanling Wu, Jiliang Deng, Nanzhu Chen, Zhaohui Zheng, Yongjun Wei, Xiaozhou Luo, and Jay D. Keasling (6 August 2020). "Promoter Architecture and Promoter Engineering in Saccharomyces cerevisiae". Metabolites. 10 (8): 320–39. doi:10.3390/metabo10080320. PMID 32781665 Check
|pmid=
value (help). Retrieved 18 September 2020. - ↑ Robert Clifford, Min-Ho Lee, Sudhir Nayak, Mitsue Ohmachi, Flav Giorgini and Tim Schedl (December 2000). "FOG-2, a novel F-box containing protein, associates with the GLD-1 RNA binding protein and directs male sex determination in the C. elegans hermaphrodite germline" (PDF). Development. 127 (24): 5265–76. PMID 11076749. Retrieved 10 August 2020.